GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Mixl1 | rn6_v1_chr13_-_97282299_97282299 | 0.38 | 2.6e-12 | Click! |
Alx1 | rn6_v1_chr7_-_44771458_44771458 | -0.34 | 2.4e-10 | Click! |
Gsx1 | rn6_v1_chr12_-_9607168_9607168 | 0.24 | 1.5e-05 | Click! |
Lbx2 | rn6_v1_chr4_+_113918740_113918740 | 0.10 | 7.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_118197217 Show fit | 72.40 |
ENSRNOT00000090922
|
5-hydroxytryptamine receptor 2C |
|
chr9_-_30844199 Show fit | 68.45 |
ENSRNOT00000017169
|
collagen type XIX alpha 1 chain |
|
chr12_-_2174131 Show fit | 54.66 |
ENSRNOT00000001313
|
Purkinje cell protein 2 |
|
chr11_+_58624198 Show fit | 46.11 |
ENSRNOT00000002091
|
growth associated protein 43 |
|
chr4_-_55011415 Show fit | 43.40 |
ENSRNOT00000056996
|
glutamate metabotropic receptor 8 |
|
chr1_+_198383201 Show fit | 39.90 |
ENSRNOT00000037405
|
seizure related 6 homolog like 2 |
|
chr9_+_73418607 Show fit | 38.93 |
ENSRNOT00000092547
|
microtubule-associated protein 2 |
|
chr13_-_76049363 Show fit | 36.29 |
ENSRNOT00000075865
ENSRNOT00000007455 |
BMP/retinoic acid inducible neural specific 2 |
|
chr7_-_28711761 Show fit | 35.10 |
ENSRNOT00000006249
|
PARP1 binding protein |
|
chr17_-_43807540 Show fit | 32.89 |
ENSRNOT00000074763
|
similar to CG31613-PA |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 89.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
28.8 | 86.4 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
5.4 | 54.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
6.5 | 52.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
3.9 | 43.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.1 | 39.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.1 | 38.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
12.7 | 38.0 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
0.5 | 37.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.5 | 36.3 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 138.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.8 | 75.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 72.4 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 57.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
7.1 | 56.7 | GO:0032584 | growth cone membrane(GO:0032584) |
5.6 | 50.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
6.3 | 38.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 35.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 33.1 | GO:0016605 | PML body(GO:0016605) |
1.5 | 30.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
28.8 | 86.4 | GO:0071886 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding(GO:0071886) |
0.3 | 78.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 57.5 | GO:0044325 | ion channel binding(GO:0044325) |
2.5 | 56.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
12.3 | 49.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 45.3 | GO:0042393 | histone binding(GO:0042393) |
10.8 | 43.4 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
3.2 | 41.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
6.3 | 38.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 33.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 75.0 | NABA COLLAGENS | Genes encoding collagen proteins |
1.0 | 49.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 38.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 32.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 29.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.6 | 20.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 17.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 15.1 | PID E2F PATHWAY | E2F transcription factor network |
0.7 | 14.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 14.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 86.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.7 | 76.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 75.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 46.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
1.9 | 42.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 24.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 23.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
1.1 | 18.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 17.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 16.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |